Leakadine

01/01/1988 - "57 patients with disseminated tumors of various sites received 10 daily doses of 600 mg/m2 leakadin intravenously. "
10/01/1996 - "In leacadin-treated patients, postimmunotherapy promotes the formation of high sanogenetic responses: an increase in the rigidity of the brain-immune system; elevations of the levels of antitumor factors of the immune system: T helper cells and locally synthesized antibodies; a decrease in neuro-sensitization after tumor removal, which prevents tumor stimulation and recurrence; an indirect reduction in the activity of T suppressors that inhibit immunological responses in growing neoplasm. "
01/01/1994 - "The antitumor immunomodulator leacadin contributes to establishment and consolidation of the tumor carrier's immunological adaptation which results in uneventful postoperative developments and recurrent-free survival."
03/01/1994 - "The paper reports the data obtained on the efficacy of a new anti-cancer immunomodulator leacadin in neurinoma of the acoustic nerve. "
10/01/1996 - "Immunotherapy with the antitumor immunomodulator leacadin in patients with acoustic neurinomas contributes to the development and optimization of the tumor carrier's immunological adaptative responses, creates conditions for the optimal postoperative course and prevents recurrence."

10/01/1996 - "Analyzing the immunological responsiveness of patients with acoustic neurinomas on the antitumor immunomodulator leacadin has revealed some significant features. "
10/01/1996 - "[A system of individual immunotherapy with leakadin in the combined therapy of acoustic neurinomas]."
03/01/1994 - "[Immunotherapy with leakadin in the combined therapy of acoustic neurinomas]."
01/01/1994 - "[Leakadin immunotherapy in the combined therapy of acoustic neurinomas]."
03/01/1994 - "The paper reports the data obtained on the efficacy of a new anti-cancer immunomodulator leacadin in neurinoma of the acoustic nerve. "

01/01/1989 - "[Dynamics of immunologic indices in patients with Kaposi's sarcoma during treatment with the preparation leakadine]."
01/01/1989 - "Changes in the immunologic parameters of 39 patients with Kaposi's sarcoma over the course of leakadin therapy were under study, i. e. "
01/01/1989 - "Since the immunomodulating effects of prospidin and leakadin are ambiguous, their combinations are advised for the treatment of Kaposi's sarcoma."

03/01/1994 - "Leacadin participates in formation of a close regulatory relation between the brain and immune system, promotes centralization of immunity regulation in conditions of surgical trauma. "

01/01/1994 - "The paper specifies the role of leacadin immunotherapy in combined treatment of acoustic nerve neurinomas. "